Apax backs Sense Proteomic spin-out
Less than a year after Apax Partners announced it was withdrawing from venture investment, the firm has led the spin-out of Sense Proteomic, a Cambridge-based biomarker discovery business, from existing portfolio company Procognia.
Apax